Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-aminobutyric acid receptor subunit rho-2 (GABRR2) is a component of ligand-gated chloride channels known as GABA(A) receptors, specifically the rho subfamily, sometimes referred to as GABA(C) receptors[1][3][4]. These pentameric ion channels mediate inhibitory synaptic transmission in the central nervous system by allowing chloride influx in response to GABA, the major inhibitory neurotransmitter in the brain. Rho-2 is particularly implicated in retinal neurotransmission, glial development in the cerebellum, and tonic inhibitory signaling in neural circuits. Genetic variations in GABRR2 have been associated with susceptibility to neuropsychiatric disorders, epilepsy, and alcohol dependence. While GABRR2 is not as widely targeted by commonly used clinical drugs as other GABA(A) subunits (e.g., those containing alpha or gamma subunits), it represents a potential therapeutic target for modulation of specific inhibitory pathways, especially in the visual system[1][3][5].
Modulation of neuron inhibition via opening of chloride channels upon GABA binding. Agonists enhance chloride flow and neuronal inhibition. Antagonists block chloride flow and reduce inhibitory effect
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid receptor subunit rho-2 (GABRR2).